2017
DOI: 10.1016/j.ejmech.2016.12.022
|View full text |Cite
|
Sign up to set email alerts
|

Piperlongumine derived cyclic sulfonamides (sultams): Synthesis and in vitro exploration for therapeutic potential against HeLa cancer cell lines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
14
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 26 publications
(14 citation statements)
references
References 26 publications
0
14
0
Order By: Relevance
“…[25]. Compound (E)-ethyl 3-(2-fluorophenyl)acrylate was synthesized by the Wittig reaction of the commercially available 2-fluorobenzaldehyde (10) with ethyl 2-(triphenyl-phosphoranylidene)acetate (11) according to the procedure described in the literature [26]. (E)-3-(2-Fluorophenyl)prop-2-en-1-ol (13) was synthesized by reducing (E)-ethyl 3-(2-fluorophenyl)acrylate (12) with diisobutylaluminium hydride (DIBAL) based on the procedure reported in the literature [27].…”
Section: Synthesismentioning
confidence: 99%
See 1 more Smart Citation
“…[25]. Compound (E)-ethyl 3-(2-fluorophenyl)acrylate was synthesized by the Wittig reaction of the commercially available 2-fluorobenzaldehyde (10) with ethyl 2-(triphenyl-phosphoranylidene)acetate (11) according to the procedure described in the literature [26]. (E)-3-(2-Fluorophenyl)prop-2-en-1-ol (13) was synthesized by reducing (E)-ethyl 3-(2-fluorophenyl)acrylate (12) with diisobutylaluminium hydride (DIBAL) based on the procedure reported in the literature [27].…”
Section: Synthesismentioning
confidence: 99%
“…Starting materials 22 and 9 were synthesized using the procedure previously described by us [23]. (E)-ethyl 3-(2-fluorophenyl)acrylate (12) was prepared from commercially available 2-fluorobenzaldehyde (10, CAS 446-52-6) according to the reported procedure [26]. (E)-3-(2-Fluorophenyl)prop-2-en-1-ol (13) was synthesized by reducing (E)-ethyl 3-(2-fluorophenyl)acrylate (12) with DIBAL based on the procedure reported in the literature [27].…”
Section: General Proceduresmentioning
confidence: 99%
“…6 Piperlongumine derived cyclic sulfonamide 2 significantly reduced the HeLa cells growth. 7 Chromone-based sulfonamide 3 ( Figure 1) showed IC 50 of 0.72 and 0.50 μmol against MCF-7 and A-549 cell lines, respectively. 8 On the other hand, two series of 1, 2, 3-triazole derivatives in our group have revealed their anticancer activity: Chalcone-1, 2, 3-triazole-azole 4 showed the potent antiproliferative activity with an IC 50 value of 1.52 μmol against SK-N-SH cancer cells and induced morphological changes; 9 1, 2, 3-Triazole-chalcone 5 (Figure 2) inhibited the proliferation of SK-N-SH cancer cells by inducing apoptosis and arresting the cell cycle at the G1 phase.…”
Section: Introductionmentioning
confidence: 99%
“…Sulfonamides have a functional group (R-SO 2 -NH 2 ) called the sulfonamide group; sulfonamide scaffolds are also very important structural motifs that are present in diverse pharmaceuticals ( Figure 1 ), showing important and extensive biological activities, such as antitumor [ 8 , 9 , 10 , 11 , 12 ], anti-inflammatory [ 13 , 14 ], and antiviral activities [ 15 , 16 ]. However, due to the structural particularity, natural products that contain a primary sulfonamide group in their structures are rare.…”
Section: Introductionmentioning
confidence: 99%